SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-23-273506
Filing Date
2023-11-08
Accepted
2023-11-08 16:06:08
Documents
91
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d540129d10q.htm   iXBRL 10-Q 1346210
2 EX-31.1 d540129dex311.htm EX-31.1 10782
3 EX-31.2 d540129dex312.htm EX-31.2 10767
4 EX-32.1 d540129dex321.htm EX-32.1 5039
5 EX-32.2 d540129dex322.htm EX-32.2 5024
  Complete submission text file 0001193125-23-273506.txt   7393470

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cprx-20230930.xsd EX-101.SCH 70230
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20230930_cal.xml EX-101.CAL 57609
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20230930_def.xml EX-101.DEF 233417
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20230930_lab.xml EX-101.LAB 465061
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20230930_pre.xml EX-101.PRE 377403
85 EXTRACTED XBRL INSTANCE DOCUMENT d540129d10q_htm.xml XML 1243951
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 231387801
SIC: 2834 Pharmaceutical Preparations